Carestream Health has signed an agreement to sell the preclinical in vivo imaging equipment product portfolio and related assets from its Molecular Imaging business to Bruker.
Carestream will retain some assets of its Molecular Imaging business, including its life science x-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment product lines, the companies said.
Carestream will continue operating its life science x-ray film business and support its in vitro product customers with service and parts. New production of the Gel Logic and Image Station in vitro products, however, will be discontinued.
Financial terms of the acquisition were not disclosed. The transaction could close in the next several weeks.
The majority of Carestream employees in the preclinical in vivo imaging business will be offered the opportunity to join Bruker.
